vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and ThredUp Inc. (TDUP). Click either name above to swap in a different company.

ThredUp Inc. is the larger business by last-quarter revenue ($79.7M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 18.5%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-3.2M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 11.1%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

ThredUp Inc. is an American company that operates an online resale platform specializing in the sale of second-hand clothing, footwear, and accessories. Founded in 2009 and headquartered in Oakland, California, it has established itself as one of the leading resale fashion marketplaces.

PBYI vs TDUP — Head-to-Head

Bigger by revenue
TDUP
TDUP
1.1× larger
TDUP
$79.7M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+9.2% gap
PBYI
27.7%
18.5%
TDUP
More free cash flow
PBYI
PBYI
$17.6M more FCF
PBYI
$14.4M
$-3.2M
TDUP
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
11.1%
TDUP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
TDUP
TDUP
Revenue
$75.5M
$79.7M
Net Profit
$-5.6M
Gross Margin
69.3%
79.6%
Operating Margin
22.7%
-8.4%
Net Margin
-7.0%
Revenue YoY
27.7%
18.5%
Net Profit YoY
74.3%
EPS (diluted)
$0.26
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
TDUP
TDUP
Q4 25
$75.5M
$79.7M
Q3 25
$54.5M
$82.2M
Q2 25
$52.4M
$77.7M
Q1 25
$46.0M
$71.3M
Q4 24
$59.1M
$67.3M
Q3 24
$80.5M
$61.5M
Q2 24
$47.1M
$66.7M
Q1 24
$43.8M
$64.5M
Net Profit
PBYI
PBYI
TDUP
TDUP
Q4 25
$-5.6M
Q3 25
$8.8M
$-4.2M
Q2 25
$5.9M
$-5.2M
Q1 25
$3.0M
$-5.2M
Q4 24
$-21.7M
Q3 24
$20.3M
$-24.8M
Q2 24
$-4.5M
$-14.0M
Q1 24
$-4.8M
$-16.6M
Gross Margin
PBYI
PBYI
TDUP
TDUP
Q4 25
69.3%
79.6%
Q3 25
77.7%
79.4%
Q2 25
76.5%
79.5%
Q1 25
77.1%
79.1%
Q4 24
76.4%
80.4%
Q3 24
63.9%
79.3%
Q2 24
77.4%
78.8%
Q1 24
75.5%
80.1%
Operating Margin
PBYI
PBYI
TDUP
TDUP
Q4 25
22.7%
-8.4%
Q3 25
17.6%
-5.3%
Q2 25
12.7%
-6.8%
Q1 25
8.7%
-7.6%
Q4 24
22.6%
-12.1%
Q3 24
27.4%
-17.0%
Q2 24
-4.6%
-14.4%
Q1 24
-5.3%
-19.2%
Net Margin
PBYI
PBYI
TDUP
TDUP
Q4 25
-7.0%
Q3 25
16.2%
-5.2%
Q2 25
11.2%
-6.7%
Q1 25
6.5%
-7.3%
Q4 24
-32.3%
Q3 24
25.2%
-40.3%
Q2 24
-9.6%
-20.9%
Q1 24
-11.0%
-25.7%
EPS (diluted)
PBYI
PBYI
TDUP
TDUP
Q4 25
$0.26
$-0.06
Q3 25
$0.17
$-0.03
Q2 25
$0.12
$-0.04
Q1 25
$0.06
$-0.04
Q4 24
$0.40
$-0.19
Q3 24
$0.41
$-0.22
Q2 24
$-0.09
$-0.13
Q1 24
$-0.10
$-0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
TDUP
TDUP
Cash + ST InvestmentsLiquidity on hand
$97.5M
$38.6M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$59.2M
Total Assets
$216.3M
$167.2M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
TDUP
TDUP
Q4 25
$97.5M
$38.6M
Q3 25
$94.4M
$46.2M
Q2 25
$96.0M
$41.0M
Q1 25
$93.2M
$41.1M
Q4 24
$101.0M
$31.9M
Q3 24
$96.7M
$43.7M
Q2 24
$96.8M
$44.8M
Q1 24
$107.2M
$50.1M
Total Debt
PBYI
PBYI
TDUP
TDUP
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
TDUP
TDUP
Q4 25
$130.3M
$59.2M
Q3 25
$115.3M
$59.1M
Q2 25
$104.7M
$60.2M
Q1 25
$97.1M
$56.1M
Q4 24
$92.1M
$56.3M
Q3 24
$71.1M
$69.3M
Q2 24
$48.5M
$86.5M
Q1 24
$51.0M
$93.5M
Total Assets
PBYI
PBYI
TDUP
TDUP
Q4 25
$216.3M
$167.2M
Q3 25
$202.9M
$172.5M
Q2 25
$194.9M
$173.6M
Q1 25
$196.2M
$172.5M
Q4 24
$213.3M
$171.2M
Q3 24
$220.7M
$214.9M
Q2 24
$205.0M
$231.2M
Q1 24
$214.1M
$244.3M
Debt / Equity
PBYI
PBYI
TDUP
TDUP
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
TDUP
TDUP
Operating Cash FlowLast quarter
$14.4M
$-1.5M
Free Cash FlowOCF − Capex
$14.4M
$-3.2M
FCF MarginFCF / Revenue
19.1%
-4.0%
Capex IntensityCapex / Revenue
0.0%
2.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$180.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
TDUP
TDUP
Q4 25
$14.4M
$-1.5M
Q3 25
$9.7M
$6.0M
Q2 25
$14.1M
$344.0K
Q1 25
$3.6M
$5.7M
Q4 24
$15.6M
$663.0K
Q3 24
$11.0M
$3.3M
Q2 24
$1.0M
$-5.0M
Q1 24
$11.2M
$1.4M
Free Cash Flow
PBYI
PBYI
TDUP
TDUP
Q4 25
$14.4M
$-3.2M
Q3 25
$9.7M
$2.4M
Q2 25
$14.1M
$-2.9M
Q1 25
$3.6M
$3.9M
Q4 24
$15.6M
$-1.8M
Q3 24
$11.0M
$1.2M
Q2 24
$1.0M
$-5.8M
Q1 24
$267.0K
FCF Margin
PBYI
PBYI
TDUP
TDUP
Q4 25
19.1%
-4.0%
Q3 25
17.7%
2.9%
Q2 25
26.8%
-3.8%
Q1 25
7.7%
5.5%
Q4 24
26.4%
-2.7%
Q3 24
13.7%
2.0%
Q2 24
2.1%
-8.7%
Q1 24
0.4%
Capex Intensity
PBYI
PBYI
TDUP
TDUP
Q4 25
0.0%
2.2%
Q3 25
0.0%
4.4%
Q2 25
0.0%
4.2%
Q1 25
0.1%
2.5%
Q4 24
0.0%
3.7%
Q3 24
0.0%
3.5%
Q2 24
0.0%
1.3%
Q1 24
0.0%
1.7%
Cash Conversion
PBYI
PBYI
TDUP
TDUP
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons